SZSE Ticker: 300439

Medicalsystem Biotechnology Co., Ltd

美康生物科技股份有限公司

美康生物

MEDICALSYSTEM

Listing Date: 2015-04-22

Board: GEM

Industry Classification: Manufacturing

【Company Frontline】Meikang Biotech adds the concept of "fangcang cabin hospital"

Post date May 20, 2022 — 17:59 Post Lock

True Vision 3 days and 2 boards! Nucleic acid sampling booth concept stocks will become the new favorite of the stock market

Post date May 15, 2022 — 22:47 Post Lock

Rumors of "false positives" once forced the stock price of Runda Medical to stop: regulatory intervention to investigate the differentiation of nucleic acid detection sector into new coronary pneumonia jqknews

Post date May 10, 2022 — 19:03 Post Lock

The "false positive" rumors once forced the stock price of Runda to stop! Regulatory involvement in the investigation, the nucleic acid detection sector is differentiated – yqqlm

Post date May 10, 2022 — 18:49 Post Lock

Meikang Bio: The company's medical laboratory actively carried out new coronavirus testing services during the epidemic

Post date May 7, 2022 — 09:26 Post Lock

Meikang Bio: There is no charge for nucleic acid testing for all employees, and the relevant costs are borne by the government

Post date May 7, 2022 — 09:26 Post Lock

Meikang Biology: At present, the 48-hour nucleic acid requirement in Ningbo is conducive to enhancing the company's market recognition and brand influence, laying the foundation for the subsequent development of the company's diagnostic services

Post date May 7, 2022 — 09:26 Post Lock

Meikang Bio: At present, the registration of new crown nucleic acid and antibody products is still actively advancing

Post date May 7, 2022 — 09:25 Post Lock

Meikang Bio: The company's cumulative nucleic acid detection volume in 2021 is about 16 million person-times

Post date May 7, 2022 — 09:17 Post Lock

Meikang Bio has obtained the medical device registration certificate of "Specific Growth Factor Detection Kit (Colorimetry)"

Post date April 18, 2022 — 20:41 Post Lock

After earning 14 billion in March, this Chinese company was frantically placed by the US government, and the outcome of the 300 billion new crown antigen test market is unpredictable

Post date April 18, 2022 — 03:04 Post Lock

What are the well-known medical device listed companies? Ranking of leading stocks of listed companies producing medical devices

Post date April 17, 2022 — 20:17 Post Lock

Meikang Bio's board secretary replied: It is actively promoting the domestic registration of three new crown detection products: nucleic acid, antibody and antigen

Post date April 15, 2022 — 12:09 Post Lock

Zhejiang Xiantong (603239): Zhejiang Xiantong-About the company's re-appointment of an accounting firm- CFi.CN Zhongcai Network

Post date April 11, 2022 — 21:22 Post Lock